Rheumatic Heart Disease: Molecules Involved in Valve Tissue Inflammation Leading to the Autoimmune Process and Anti-S. pyogenes Vaccine
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 352
- https://doi.org/10.3389/fimmu.2013.00352
Abstract
The major events leading to both rheumatic fever and rheumatic heart disease are reviewed. Several genes are involved in the development of rheumatic fever (RF) and rheumatic heart disease (RHD). The inflammatory process that results from S. pyogenes infection involves the activation of several molecules such as VCAM and ICAM, which play a role in the migration of leukocytes to the heart, particularly to the valves. Specific chemokines, such as CXCL3/MIP1α as well as CCL1/I309 and CXCL9/Mig, attract T cells to the myocardium and valves, respectively. The autoimmune reactions are mediated by both the B- and T-cell responses that begin at the periphery, followed by the migration of T-cell clones to the heart and the infiltration of heart lesions in RHD patients. These cells recognize streptococcal antigens and human tissue proteins. Molecular mimicry between streptococcal M protein and human proteins has been proposed as the triggering factor leading to autoimmunity in RF and RHD. The production of cytokines from peripheral and heart-infiltrating mononuclear cells suggests that T helper 1 (Th1) and Th17 cytokines are the mediators of RHD heart lesions. The low numbers of IL-4-producing cells in the valvular tissue might contribute to the maintenance and progression of the valve lesions. The identification of a vaccine epitope opens a perspective of development of an effective and safe vaccine to prevent S. pyogenes infections, consequently RF and RHD.This publication has 39 references indexed in Scilit:
- Rheumatic heart disease: mediation by complex immune events.2011
- Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart diseaseClinical and Experimental Immunology, 2009
- Association of Mannose-Binding Lectin Gene Polymorphism but Not of Mannose-Binding Serine Protease 2 with Chronic Severe Aortic Regurgitation of Rheumatic EtiologyClinical and Vaccine Immunology, 2008
- Gene Polymorphisms of TNF-α−308, IL-10−1082, IL-6−174, and IL-1RaVNTR Related to Susceptibility and Severity of Rheumatic Heart DiseasePediatric Cardiology, 2007
- Association of polymorphisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic feverMolecular Immunology, 2007
- The Association Between Mannose-Binding Lectin Gene Polymorphism and Rheumatic Heart DiseaseHuman Immunology, 2006
- TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha productionJournal of Autoimmunity, 2005
- Acute rheumatic feverThe Lancet, 2005
- TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in childrenJournal of Molecular Medicine, 2005
- Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart diseaseJournal of Autoimmunity, 2003